查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941846

北美静脉输液治疗市场规模、份额和趋势分析报告：按服务、组件、提供者类型、最终用途、国家和细分市场预测（2026-2033 年）

North America IV Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider Type, By End Use, By Country, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

北美静脉输液治疗市场概况

预计到 2025 年，北美静脉输液疗法的市场规模将达到 13.5 亿美元，预计到 2033 年将达到 25.6 亿美元。

预计从 2026 年到 2033 年，该市场将以 8.6% 的复合年增长率成长。推动该市场成长的主要因素是消费者对积极健康管理的兴趣日益浓厚、向预防性健康理念的转变以及对便捷、按需医疗保健服务的需求不断增长。

疫情后人们健康意识的提高显着加速了静脉输液作为一种生活方式和復健方法的普及。同时，随着疲劳、偏头痛和营养不良等疾病发生率的增加，静脉输液疗法的治疗范围也正在超越其传统的临床应用。

随着癌症、糖尿病等慢性疾病的日益普遍，北美地区的静脉输液治疗产业也持续成长。根据美国疾病管制与预防中心（CDC）2024年2月的估计，美国约有1.29亿人患有至少一种重大慢性疾病，使得对有效医疗解决方案的需求激增。静脉输液治疗作为一种直接、快速的手段，在应对和控制慢性疾病的影响方面发挥着至关重要的作用。它正逐渐成为改善慢性病患者健康状况的重要工具。随着慢性病盛行率的上升，市场也不断扩大，为有需要的患者提供专业的照护和支援。

北美地区对静脉输液疗法益处的认识不断提高，正在推动市场成长。英国国家健康与临床优化研究所 (NICE) 指出，许多成年患者需要接受静脉输液疗法来调节体液和电解质平衡。静脉输液疗法是治疗性介入，旨在补充体液并恢復身体功能。值得注意的是，由于它绕过了消化器官系统，因此与口服给药相比，维生素、电解质和抗氧化剂的吸收速度更快、更充分。

静脉输液疗法广泛应用于多个临床领域，以确保快速有效地进行体液和电解质管理。在急诊和重症监护中，它能为创伤、休克、败血症和急性脱水患者提供即时復苏。在胃肠道疾病中，它有助于控制因严重呕吐、腹泻或发炎性肠道疾病引起的体液流失。在术后护理中，静脉输液疗法用于维持体液平衡、给药，并在口服摄取受限的情况下支持患者復健。在肿瘤科，它能预防化疗和放疗期间的脱水和疲劳。在慢性病管理中，它能为口服摄取受限的糖尿病、肾臟病和心血管疾病患者提供支援。

静脉输液疗法的需求日益增长，也推动了便利、个人化健康管理方案的兴起，这些方案超越了传统的临床照护。例如，2025年8月，AquaPulse IV在维吉尼亚弗雷德里克斯堡推出了行动静脉输液服务。这项服务由合格的医疗保健专业人员提供客製化的补充液体和维生素输液，直接送到患者家中、职场和活动场所。这项发展表明，静脉输液疗法正逐渐成为生活方式和预防保健的重要组成部分，能够在无缝融入日常生活的环境中，帮助患者快速恢復、增强活力并提升免疫力。这些按需服务模式凸显了健康服务领域对便利性和以病人为中心的照护日益增长的关注。

目录

第一章：调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场趋势展望
  • 市场动态
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析

第四章：北美静脉输液治疗市场：服务估算与趋势分析

  • 服务市占率变化分析（2025 年和 2033 年）
  • 按服务分類的市场规模、预测和趋势分析（2021-2033 年）
  • 免疫增强剂
  • 能量增强剂
  • 水合作用
  • 美与美学
  • 排毒
  • 长寿与抗老
  • 运动能力和竞技水平
  • 缓解偏头痛
  • 压力、睡眠和情绪支持
  • 流感和肠胃炎
  • 其他的

第五章 北美静脉输液治疗市场：依成分分類的估算与趋势分析

  • 按组成部分分類的市占率波动分析（2025 年和 2033 年）
  • 按组件分類的市场规模、预测和趋势分析（2021年至2033年）
  • 含有药物成分
  • 非药用

第六章 北美静脉输液治疗市场：按服务提供者类型分類的估算和趋势分析

  • 提供者类型仪表板
  • 按供应商类型分類的市占率波动分析（2025 年和 2033 年）
  • 按供应商类型分類的市场规模、预测和趋势分析（2021-2033 年）
  • 行动电信商
  • 实体提供者

第七章 北美静脉输液治疗市场：依最终用途分類的估算与趋势分析

  • 按最终用途分類的市占率变化分析（2025 年和 2033 年）
  • 按最终用途分類的市场规模、预测和趋势分析（2021-2033年）
  • 医疗保健提供者
  • 医院和诊所
  • 健康中心及水疗中心
  • 居家医疗
  • 其他的

第八章：北美静脉输液疗法市场：国别估算与趋势分析

  • 各国市场概览
  • 各国市场：要点
  • 我们
    • 主要国家的趋势
    • 法律规范
    • 竞争考察
  • 加拿大
    • 主要国家的趋势
    • 法律规范
    • 竞争考察
  • 墨西哥
    • 主要国家的趋势
    • 法律规范
    • 竞争考察

第九章 竞争情势

  • 参与公司概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/列表
    • Baxter
    • B. Braun SE
    • Otsuka Pharmaceutical Co., Ltd.
    • Grifols, SA
    • Vifor Pharma Management Ltd.
    • JW Life Science Corporation
    • Amanta Healthcare
    • NexGen Health
    • Core IV Therapy, LLC
    • Drip Hydration
    • REVIV
    • DriPros IV Hydration Wellness
    • wHydrate
    • Renew Ketamine &Wellness Center
    • R2 Medical Clinic
    • AliveDrip
    • Hydrate IV
    • Hydration Room
Product Code: GVR-4-68040-161-3

North America IV Hydration Therapy Market Summary

The North America IV hydration therapy market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.56 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services.

Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.

The North America IV hydration therapy industry is rising, owing to the increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates of February 2024, around 129 million people in the US have at least 1 major chronic disease, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address the consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it.

Increasing awareness of the benefits of IV hydration therapies among North America's population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy is a therapeutic intervention that delivers fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.

IV hydration therapy is utilized across multiple clinical areas to ensure rapid and effective fluid and electrolyte management. In emergency and critical care, it provides immediate resuscitation for trauma, shock, sepsis, and acute dehydration. For gastrointestinal disorders, it helps manage fluid loss from severe vomiting, diarrhea, or inflammatory bowel conditions. Post-surgical care relies on IV therapy to maintain fluid balance, deliver medications, and support recovery when oral intake is limited. In oncology, it prevents dehydration and fatigue during chemotherapy and radiation, while in chronic disease management, it supports patients with diabetes, renal, or cardiovascular conditions who have restricted oral intake.

The increasing demand for IV hydration therapy is also driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

North America IV Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America IV hydration therapymarket report based on service, component, provider type, end use, and regions.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune Boosters
  • Energy Boosters
  • Hydration
  • Beauty/ Aesthetics
  • Detoxification
  • Longevity/ Antiaging
  • Performance/ Athletics
  • Migraine & Pain Relief
  • Stress/Sleep/Mood Support
  • Flu/Stomach
  • Others
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Medicated
  • Non-medicated
  • Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Mobile Providers
  • Physical Providers
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Wellness Centers and Spas
  • Home Healthcare
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada
  • Mexico

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Component
    • 1.2.3. Provider Type
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
      • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
      • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
      • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
      • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Pricing Analysis
    • 3.2.6. Emerging Trends
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. North America IV Hydration Therapy Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Service Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Immune Boosters
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Energy Boosters
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydration
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Beauty/ Aesthetics
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Detoxification
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Longevity/ Antiaging
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Performance/ Athletics
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Migraine & Pain Relief
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Stress/Sleep/Mood Support
    • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Flu/Stomach
    • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America IV Hydration Therapy Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Medicated
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Medicated
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America IV Hydration Therapy Market: Provider Type Estimates & Trend Analysis

  • 6.1. Provider Type Dashboard
  • 6.2. Provider Type Market Share Movement Analysis, 2025& 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
  • 6.4. Mobile Providers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Physical Providers
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America IV Hydration Therapy Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Wellness Centers & Spas
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Healthcare
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America IV Hydration Therapy Market: Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market: Key Takeaways
  • 8.3. U.S.
    • 8.3.1. Key country dynamic
    • 8.3.2. Regulatory framework
    • 8.3.3. Competitive insights
    • 8.3.4. U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key country dynamic
    • 8.4.2. Regulatory framework
    • 8.4.3. Competitive insights
    • 8.4.4. Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Mexico
    • 8.5.1. Key country dynamic
    • 8.5.2. Regulatory framework
    • 8.5.3. Competitive insights
    • 8.5.4. Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Baxter
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. B. Braun SE
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols, S.A.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma Management Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. JW Life Science Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Amanta Healthcare
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. NexGen Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Core IV Therapy, LLC
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Drip Hydration
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. REVIV
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. DriPros IV Hydration Wellness
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. wHydrate
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Renew Ketamine & Wellness Center
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. R2 Medical Clinic
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. AliveDrip
      • 9.5.16.1. Overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Hydrate IV
      • 9.5.17.1. Overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Hydration Room
      • 9.5.18.1. Overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product benchmarking
      • 9.5.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America IV Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 6 North America IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 7 North America IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 10 U.S. IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 11 U.S. IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 14 Canada IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 15 Canada IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 18 Mexico IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 19 Mexico IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America IV Hydration Therapy market: Market outlook
  • Fig. 5 North America IV Hydration Therapy market: Segment outlook
  • Fig. 6 North America IV Hydration Therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 North America IV Hydration Therapy Market Driver Impact
  • Fig. 9 North America IV Hydration Therapy market Restraint impact
  • Fig. 10 North America IV Hydration Therapy market, Service outlook key takeaways (USD Million)
  • Fig. 11 North America IV Hydration Therapy market: Service movement analysis (USD Million)
  • Fig. 12 Immune Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Energy Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hydration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Beauty/ Aesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Detoxification market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Longevity/ Antiaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Performance/ Athletics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Migraine & Pain Relief market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Stress/Sleep/Mood Support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Flu/Stomach market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 North America IV Hydration Therapy market, component outlook: Key takeaways, (USD Million)
  • Fig. 24 North America IV Hydration Therapy market: component movement analysis, (USD Million)
  • Fig. 25 Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 North America IV Hydration Therapy market, provider type outlook key takeaways (USD Million)
  • Fig. 28 North America IV Hydration Therapy market: provider type movement analysis, (USD Million)
  • Fig. 29 Mobile Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Physical Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 North America IV Hydration Therapy market, end use outlook key takeaways (USD Million)
  • Fig. 32 North America IV Hydration Therapy market: end use movement analysis, (USD Million)
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Wellness Centers & Spas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Home Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Country marketplace: Key takeaways
  • Fig. 38 North America IV Hydration Therapy market: Country outlook, 2025 & 2033
  • Fig. 39 U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)